Nectar Lifesciences Ltd

NSE: NECLIFE · BSE: 532649 · Pharmaceuticals & Biotechnology · 4 announcements

Share price: ₹10.84
Market cap: ₹243.1 Cr
Revenue (annual): ₹0.00 Cr
Net profit (annual): ₹-292.9 Cr
P/E (TTM): -1.0×Sector 50.4×
Promoter holding: 51.84%+0.00% QoQ
FII holding: 0.50%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Management Change 1 Financial Results 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

18 Sep 2026 16:11 IST BSE

Management Change

Nectar Lifesciences Management Change

Nectar Lifesciences Limited has announced the appointment of Dr. Gunmala Suri as a Director. Additionally, three other directors have been re-appointed to the Board.

Read the filing ↗

18 Sep 2026 12:25 IST NSE

Annual General Meeting

Nectar Lifesciences Annual General Meeting

Nectar Lifesciences filed proceedings of its 31st AGM held September 18, 2026. Resolutions covered adoption of FY26 financials and director re-appointments.

Read the filing ↗

14 Aug 2026 20:47 IST BSE

Financial Results

Nectar Lifesciences Q1 FY27 Results: Net Loss of ₹15.4 Cr, Loss Narrows

Nectar Lifesciences Ltd reported revenue from operations of ₹0.4 Cr and a net loss of ₹15.4 Cr for Q1 FY27.

Key figure: Net loss ₹15.4 Cr

Open full results → Read the filing ↗